Literature DB >> 10334367

Reconstruction of the irradiated contracted socket with an expanded superficial temporalis fascial flap.

J A Foster1, E Castro, F A Papay.   

Abstract

PURPOSE: To describe the reconstruction of an irradiated contracted socket with an expanded superficial temporalis fascial flap and oral mucosa.
METHODS: A superficial temporalis fascial flap was first expanded with tissue expansion techniques and then rotated into the orbit to revascularize the socket. The mucosal surface of the socket was secondarily grafted with buccal and hard palate mucosa.
RESULTS: The expanded superficial temporalis fascial flap was used to revascularize the socket for grafting with hard palate and buccal mucosa. This resulted in the successful retention of an ocular prosthesis.
CONCLUSION: The expanded superficial temporalis fascial flap is a useful technique in reconstruction of the contracted socket.

Entities:  

Mesh:

Year:  1999        PMID: 10334367     DOI: 10.1016/s0002-9394(98)00429-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Rigid nylon foil-anchored polytetrafluoroetyhlene (Gore-Tex) sheet stenting for conjunctival fornix reconstruction.

Authors:  Hakan Demirci; Susan G Elner; Victor M Elner
Journal:  Ophthalmology       Date:  2010-08-05       Impact factor: 12.079

2.  Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma.

Authors:  Qasiem J Nasser; Dan S Gombos; Michelle D Williams; B Ashleigh Guadagnolo; William H Morrison; Adam S Garden; Beth M Beadle; Elvia Canseco; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 May-Jun       Impact factor: 1.746

3.  Comparative analysis of use of porous orbital implant with mucus membrane graft and dermis fat graft as a primary procedure in reconstruction of severely contracted socket.

Authors:  Kasturi Bhattacharjee; Harsha Bhattacharjee; Ganesh Kuri; Jayanta Kr Das; Debleena Dey
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.